Edition:
India

Anixa Biosciences Inc (ANIX.OQ)

ANIX.OQ on NASDAQ Stock Exchange Capital Market

2.43USD
30 Sep 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.43
Open
$2.56
Day's High
$2.60
Day's Low
$2.37
Volume
49,022
Avg. Vol
74,462
52-wk High
$4.15
52-wk Low
$1.33

Select another date:

Mon, Jul 6 2020

BRIEF-Anixa, Ontochem Announce Completion Of Initial Screening Program And Identification Of Additional Covid-19 Compounds

* ANIXA AND ONTOCHEM ANNOUNCE COMPLETION OF INITIAL SCREENING PROGRAM AND IDENTIFICATION OF ADDITIONAL COVID-19 COMPOUNDS Source text for Eikon: Further company coverage:

BRIEF-Anixa Announces Strategic Program Realignment Focused On Advancement Of Therapeutic, Vaccine Pipeline

* ANIXA ANNOUNCES STRATEGIC PROGRAM REALIGNMENT FOCUSED ON ADVANCEMENT OF ITS THERAPEUTIC AND VACCINE PIPELINE

BRIEF-Anixa Biosciences And Ontochem Have Synthesized Four Potential Covid-19 Drugs For Testing In Biological Assays

* ANIXA BIOSCIENCES AND ONTOCHEM HAVE SYNTHESIZED FOUR POTENTIAL COVID-19 DRUGS FOR TESTING IN BIOLOGICAL ASSAYS Source text for Eikon: Further company coverage:

BRIEF-Anixa Biosciences And Ontochem Announce Discovery Of First Covid-19 Therapeutic Candidate

* ANIXA BIOSCIENCES AND ONTOCHEM ANNOUNCE DISCOVERY OF FIRST COVID-19 THERAPEUTIC CANDIDATE

BRIEF-Anixa Biosciences Announces Publication Of Peer-Reviewed Article In Biomarker Insights

* ANIXA BIOSCIENCES ANNOUNCES PUBLICATION OF PEER-REVIEWED JOURNAL ARTICLE IN BIOMARKER INSIGHTS HIGHLIGHTING CCHEK™ LIQUID BIOPSY TECHNOLOGY Source text for Eikon: Further company coverage:

BRIEF-Anixa Biosciences And Ontochem Announce Collaboration To Develop Novel COVID-19 Therapeutics

* ANIXA BIOSCIENCES AND ONTOCHEM ANNOUNCE COLLABORATION TO DEVELOP NOVEL COVID-19 THERAPEUTICS Source text for Eikon: Further company coverage:

Select another date: